Mayo Clinic Health System

La Crosse, Wisconsin 54601-4795

0 studies enrolling now · 5 studies all time

What they study most

Acute Coronary Syndrome, Acute Lung Injury, Acute Respiratory Distress Syndrome, COVID-19 Severe Pneumonia, Coronary Artery Disease, Dyslipidemia, Pneumonia, Viral, Stenosis, Type2 Diabetes

Studies at this site

• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Firehawk Rapamycin Target Eluting Coronary Stent North American Trial — Running, not enrolling
• Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia — Stopped early
• Tailored Antiplatelet Therapy Following PCI — Completed